TrademarkDir
CELLESTIA
LIVE

Serial Number

79246636

Owner

Cellestia Biotech AG

Attorney

Anthony E. Bennett

Filing Date

Nov 1, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CELLESTIA Trademark

Serial Number: 79246636 • Registration: 6098248

CELLESTIA is a trademark filed by Cellestia Biotech AG on November 1, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cellestia Biotech AG

Hochbergerstrasse 60C

Entity Type: 25

Trademark Details

Filing Date

November 1, 2018

Registration Date

July 14, 2020

Published for Opposition

September 24, 2019

Goods & Services

Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, namely small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of NOTCH-dependent cancers; medicinal preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; veterinary medicines for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders

Chemical products for use in industry and science, namely, chemicals for use in the manufacture of pharmaceutical and veterinary products; Chemicals for use in biotechnological product development

Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals; research, development of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 14, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 3, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 14, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 4, 2020 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 15, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2020 OPNR
POST PUBLICATION AMENDMENT - ENTERED
Mar 26, 2020 CHPB
ASSIGNED TO PETITION STAFF
Mar 25, 2020 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 24, 2020 EPPA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2020 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2020 COAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 22, 2019 ETOF
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 8, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 20, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 7, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 4, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 29, 2018 REPR

Related Trademarks